04:53 PM EDT, 03/19/2024 (MT Newswires) -- Tyra Biosciences ( TYRA ) reported a Q4 net loss late Tuesday of $0.53 per diluted share, compared with a loss of $0.31 per share a year earlier.

Analysts polled by Capital IQ expected a loss of $0.48.

As expected, no revenue for the quarter ended Dec. 31 was reported.

The company said that it expects its pro-forma cash position of about $403.5 million to support its key clinical and operational milestones through at least 2026.